Can machine learning predict drug nanocrystals?

被引:61
作者
He, Yuan [1 ]
Ye, Zhuyifan [1 ]
Liu, Xinyang [1 ]
Wei, Zhengjie [1 ]
Qiu, Fen [1 ]
Li, Hai-Feng [2 ]
Zheng, Ying [1 ]
Ouyang, Defang [1 ]
机构
[1] Univ Macau, Inst Chinese Med Sci ICMS, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[2] Univ Macau, Inst Appl Phys & Mat Engn, Macau, Peoples R China
关键词
Machine learning; Nanocrystals; Particle size; Polydispersity index (PDI); Prediction; POORLY SOLUBLE DRUGS; FORMULATION DEVELOPMENT; NANOSUSPENSIONS; TECHNOLOGY; SOLUBILITY; DELIVERY; BIOAVAILABILITY; DISCOVERY; FEATURES;
D O I
10.1016/j.jconrel.2020.03.043
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanocrystals have exhibited great advantage for enhancing the dissolution rate of water insoluble drugs due to the reduced size to nanoscale. However, current pharmaceutical approaches for nanocrystals formulation development highly depend on the expert experience and trial-and-error attempts which remain time and resource consuming. In this research, we utilized machine learning techniques to predict the particle size and polydispersity index (PDI) of nanocrystals. Firstly, 910 nanocrystal size data and 341 PDI data by three preparation methods (ball wet milling (BWM) method, high-pressure homogenization (HPH) method and antisolvent precipitation (ASP) method) were collected for the construction of the prediction models. The results demonstrated that light gradient boosting machine (LightGBM) exhibited well performance for the nanocrystals size and PDI prediction with BWM and HPH methods, but relatively poor predictions for ASP method. The possible reasons for the poor prediction refer to low quality of data because of the poor reproducibility and instability of nanocrystals by ASP method, which also confirm that current commercialized products were mainly manufactured by BWM and HPH approaches. Notably, the contribution of the influence factors was ranked by the LightGBM, which demonstrated that milling time, cycle index and concentration of stabilizer are crucial factors for nanocrystals prepared by BWM, HPH and ASP, respectively. Furthermore, the model generalizations and prediction accuracies of LightGBM were confirmed experimentally by the newly prepared nanocrystals. In conclusion, the machine learning techniques can be successfully utilized for the predictions of nanocrystals prepared by BWM and HPH methods. Our research also reveals a new way for nanotechnology manufacture.
引用
收藏
页码:274 / 285
页数:12
相关论文
共 38 条
  • [1] Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications
    Ahire, Eknath
    Thakkar, Shreya
    Darshanwad, Mahesh
    Misra, Manju
    [J]. ACTA PHARMACEUTICA SINICA B, 2018, 8 (05) : 733 - 755
  • [2] Nanosizing techniques for improving bioavailability of drugs
    Al-Kassas, Raida
    Bansal, Mahima
    Shaw, John
    [J]. JOURNAL OF CONTROLLED RELEASE, 2017, 260 : 202 - 212
  • [3] Comparison of nanosuspensions and hydroxypropyl-β-cyclodextrin complex of melarsoprol: Pharmacokinetics and tissue distribution in mice
    Ben Zirar, Siham
    Astier, Alain
    Muchow, Marc
    Gibaud, Stephane
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (02) : 649 - 656
  • [4] Machine learning for molecular and materials science
    Butler, Keith T.
    Davies, Daniel W.
    Cartwright, Hugh
    Isayev, Olexandr
    Walsh, Aron
    [J]. NATURE, 2018, 559 (7715) : 547 - 555
  • [5] Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation
    Chen, Lijiang
    Wang, Yongjie
    Zhang, Jiaozhen
    Hao, Leilei
    Guo, Hejian
    Lou, Hongxiang
    Zhang, Dianrui
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (01) : 160 - 169
  • [6] Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson's Disease
    Chen, Tongkai
    Li, Chuwen
    Li, Ye
    Yi, Xiang
    Lee, Simon Ming-Yuen
    Zheng, Ying
    [J]. MOLECULAR PHARMACEUTICS, 2016, 13 (11) : 3864 - 3875
  • [7] Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
    Danaei, M.
    Dehghankhold, M.
    Ataei, S.
    Davarani, F. Hasanzadeh
    Javanmard, R.
    Dokhani, A.
    Khorasani, S.
    Mozafari, M. R.
    [J]. PHARMACEUTICS, 2018, 10 (02)
  • [8] Dual centrifugation - A new technique for nanomilling of poorly soluble drugs and formulation screening by an DoE-approach
    Hagedorn, Martin
    Boegershausen, Ansgar
    Rischer, Matthias
    Schubert, Rolf
    Massing, Ulrich
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 530 (1-2) : 79 - 88
  • [9] Predicting physical stability of solid dispersions by machine learning techniques
    Han, Run
    Xiong, Hui
    Ye, Zhuyifan
    Yang, Yilong
    Huang, Tianhe
    Jing, Qiufang
    Lu, Jiahong
    Pan, Hao
    Ren, Fuzheng
    Ouyang, Defang
    [J]. JOURNAL OF CONTROLLED RELEASE, 2019, 311 : 16 - 25
  • [10] Predicting oral disintegrating tablet formulations by neural network techniques
    Han, Run
    Yang, Yilong
    Li, Xiaoshan
    Ouyang, Defang
    [J]. ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 13 (04) : 336 - 342